Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S340000, C514S395000, C544S279000, C546S272400, C548S255000
Reexamination Certificate
active
08003657
ABSTRACT:
The present invention relates to heterocyclic substituted bisarylurea derivatives of formula I, the use of the compounds of formula I as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
REFERENCES:
patent: 2003/0027914 (2003-02-01), Suzuki et al.
patent: 2003/0144278 (2003-07-01), Riedl et al.
patent: 2004/0014756 (2004-01-01), Michaelides et al.
patent: 99/32436 (1999-07-01), None
patent: 01/51456 (2001-07-01), None
patent: 01/57008 (2001-08-01), None
patent: 02/44156 (2002-06-01), None
patent: 02/092576 (2002-11-01), None
patent: 03/068223 (2003-08-01), None
patent: WO 03/099771 (2003-12-01), None
patent: 2005/075425 (2005-08-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Manley et al., Urea derivatives of STI571 as inhibitors of Bcr-Abl and PDGFR kinases, Bioorganic & Medicinal Chemistry Letters, vol. 14, Issue 23, pp. 5793-5797, (2004) .
Buchstaller Hans-Peter
Burgdorf Lars Thore
Greiner Hartmut
Hoelzemann Guenter
Jonczyk Alfred
Davis Zinna Northington
Merck Patent GmbH
Perkins Coie LLP
LandOfFree
Heterocyclic substituted bisarylurea derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic substituted bisarylurea derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic substituted bisarylurea derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2662630